NEW YORK, NY / ACCESSWIRE / December 30, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trulieve Cannabis Corp. ("Trulieve" or the Company") (TCNNF). Investors who purchased Trulieve securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/tcnnf.
The investigation concerns whether Trulieve and certain of its officers and/or directors have violated federal securities laws.
On December 17, 2019, Grizzly Research published an article reporting that most of the Company's cultivation space comes from "hoop houses that produce low quality output," that there were extensive ties between Trulieve and ongoing FBI investigations into corruption, that the Company's initial license approval "stinks of corruption," and that the Company engaged in several undisclosed related party transactions. On this news, Trulieve's stock price fell $1.51 per share, or over 12.6%, to close at $10.40 per share on December 17, 2019.
If you are aware of any facts relating to this investigation, or purchased Trulieve shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/tcnnf. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com: